The SAFE-PN tool allows you to solidify your knowledge in the sterile preparations field - ideal for professionals and students.
Watch the video below and identify errors made during parenteral nutrition preparation.
![[team] image of pharmacist preparing medication](https://cdn.prod.website-files.com/68d3e2fccca7a66eb2dea239/68d816fc66c49500c77d1e56_ChatGPT%20Image%2027_09_2025%2C%2017_54_56.png)
This video aims to simulate the preparation of parenteral nutrition using either manual or semi-automatic methods. However, errors were made deliberately - the goal is to detect them all.
Any errors detected while viewing the video must be reported using the Office Forms link provided.
Feedback with evaluation results will be sent exclusively to the indicated email address.
This initiative has non-profit educational and scientific purposes. By participating in this survey, you are contributing to an assessment of the scientific community's knowledge on parenteral nutrition preparation and to the creation of guidelines capable of evaluating and training qualified professionals for this type of preparation.
The SAFE-PN tool aims to assess the ability of professionals and students in the field of Pharmacy and Pharmaceutical Sciences to detect errors deliberately made during the preparation of parenteral nutrition using either a manual or semi-automatic method. The proposed exercise allows the viewing of a simulation in asynchronous video format, increasing the accessibility of the assessment, anywhere, by any professional.
Participating in this survey does not imply any costs, nor does it involve sharing personal data. Any data provided by participants may be used for research and scientific dissemination purposes, but always in aggregated form. The anwsers of participants may be disseminated within the scientific community but as a group, never individual responses. No personal information or data about participants will be disclosed.
Feedback on this survey will be sent exclusively to the email address provided by the participant. Access to the submissions will be limited to the four researchers involved (Ângelo Jesus, Fernando Moreira, Mariana Nascimento, and Sofia Vieira). The researchers attest, under oath, that they will not share the data they have access to with third parties. Participation is subject to informed consent.
